{"id":"https://openalex.org/W4416630105","doi":"https://doi.org/10.1158/1078-0432.30710179","title":"Figure S1-S6 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer","display_name":"Figure S1-S6 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer","alternate_titles":[],"publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416630105","doi":"https://doi.org/10.1158/1078-0432.30710179"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30710179","doi":"https://doi.org/10.1158/1078-0432.30710179","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30710179","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1-S6_from_Urinary_Tumor_DNA_MRD_Analysis_to_Identify_Responders_to_Neoadjuvant_Immunotherapy_in_Muscle-invasive_Bladder_Cancer/30710179/1/files/59835013.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4416630105"],"child_works_count":0,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1-S6_from_Urinary_Tumor_DNA_MRD_Analysis_to_Identify_Responders_to_Neoadjuvant_Immunotherapy_in_Muscle-invasive_Bladder_Cancer/30710179/1/files/59835013.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041339469","display_name":"Ruiyun Zhang","orcid":"https://orcid.org/0000-0003-3501-646X","observed_orcids":["https://orcid.org/0000-0003-3501-646X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruiyun Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3501-646X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035234845","display_name":"Jingyu Zang","orcid":"https://orcid.org/0000-0001-9416-2323","observed_orcids":["https://orcid.org/0000-0001-9416-2323"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingyu Zang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9416-2323","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027535273","display_name":"Di Jin","orcid":"https://orcid.org/0009-0002-2769-536X","observed_orcids":["https://orcid.org/0009-0002-2769-536X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Di Jin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-2769-536X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032529616","display_name":"Feng Xie","orcid":"https://orcid.org/0009-0003-4849-007X","observed_orcids":["https://orcid.org/0009-0003-4849-007X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Feng Xie","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-4849-007X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034213895","display_name":"Akezhouli Shahatiaili","orcid":"https://orcid.org/0009-0001-3792-558X","observed_orcids":["https://orcid.org/0009-0001-3792-558X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akezhouli Shahatiaili","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-3792-558X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020602841","display_name":"Guangyu Wu","orcid":"https://orcid.org/0000-0002-7043-2357","observed_orcids":["https://orcid.org/0000-0002-7043-2357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guangyu Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7043-2357","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101905191","display_name":"Lu Zhang","orcid":"https://orcid.org/0000-0003-2137-2893","observed_orcids":["https://orcid.org/0000-0003-2137-2893"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lu Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2137-2893","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068729600","display_name":"Lu Wang","orcid":"https://orcid.org/0009-0004-8704-9153","observed_orcids":["https://orcid.org/0009-0004-8704-9153"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lu Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-8704-9153","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017571148","display_name":"Yue Zhang","orcid":"https://orcid.org/0009-0003-7915-5258","observed_orcids":["https://orcid.org/0009-0003-7915-5258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yue Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-7915-5258","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082959448","display_name":"Zhixin Zhao","orcid":"https://orcid.org/0009-0001-6922-9650","observed_orcids":["https://orcid.org/0009-0001-6922-9650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhixin Zhao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-6922-9650","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075682354","display_name":"Pan Du","orcid":"https://orcid.org/0000-0002-4561-6883","observed_orcids":["https://orcid.org/0000-0002-4561-6883"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pan Du","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4561-6883","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077970099","display_name":"Shidong Jia","orcid":"https://orcid.org/0000-0001-5854-819X","observed_orcids":["https://orcid.org/0000-0001-5854-819X","https://orcid.org/0009-0006-3823-8227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shidong Jia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-3823-8227","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024833333","display_name":"Jinhai Fan","orcid":"https://orcid.org/0000-0002-0153-1159","observed_orcids":["https://orcid.org/0000-0002-0153-1159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jinhai Fan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0153-1159","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059666944","display_name":"Guanglei Zhuang","orcid":"https://orcid.org/0000-0003-3088-177X","observed_orcids":["https://orcid.org/0000-0003-3088-177X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guanglei Zhuang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3088-177X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056252602","display_name":"Haige Chen","orcid":"https://orcid.org/0000-0002-1846-8141","observed_orcids":["https://orcid.org/0000-0002-1846-8141","https://orcid.org/0000-0002-5194-2087"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haige Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1846-8141","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urinary-tumor-dna","display_name":"urinary tumor DNA","score":0.8889999985694885},{"id":"https://openalex.org/keywords/neoadjuvant-immunotherapy","display_name":"neoadjuvant immunotherapy","score":0.8199999928474426},{"id":"https://openalex.org/keywords/toripalimab","display_name":"toripalimab","score":0.9470000267028809},{"id":"https://openalex.org/keywords/muscle-invasive-bladder-cancer","display_name":"muscle-invasive bladder cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9599999785423279},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.824999988079071},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7329999804496765},{"id":"https://openalex.org/keywords/tertiary-lymphoid-structures","display_name":"tertiary lymphoid structures","score":0.9480000138282776},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tumor-fraction-estimation","display_name":"tumor fraction estimation","score":0.7580000162124634},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.628000020980835},{"id":"https://openalex.org/keywords/mutational-landscape","display_name":"mutational landscape","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.5600000023841858},{"id":"https://openalex.org/keywords/mri-response-assessment","display_name":"MRI response assessment","score":0.5680000185966492},{"id":"https://openalex.org/keywords/whole-exome-sequencing","display_name":"exome sequencing","score":0.5709999799728394},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.546999990940094},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7160000205039978},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.567799985408783},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5318999886512756},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.501800000667572},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48919999599456787},{"id":"https://openalex.org/C2779529041","wikidata":"https://www.wikidata.org/wiki/Q22349364","display_name":"Liquid biopsy","level":3,"score":0.47839999198913574},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4569999873638153},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.43549999594688416},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42399999499320984},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.4090000092983246},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4018999934196472},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.38609999418258667},{"id":"https://openalex.org/C163565370","wikidata":"https://www.wikidata.org/wiki/Q4308623","display_name":"Mutation testing","level":4,"score":0.36880001425743103},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.3506999909877777},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.3465999960899353},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3416000008583069},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.301800012588501},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.29330000281333923},{"id":"https://openalex.org/C2779762690","wikidata":"https://www.wikidata.org/wiki/Q9382","display_name":"Urinary bladder","level":2,"score":0.2808000147342682},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.27489998936653137},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.2727999985218048},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2705000042915344},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.2678000032901764},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.26750001311302185},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.2648000121116638},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2646999955177307},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.26330000162124634},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C40993552","wikidata":"https://www.wikidata.org/wiki/Q514654","display_name":"Gold standard (test)","level":2,"score":0.25929999351501465},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.25859999656677246},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.2572000026702881}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30710179","doi":"https://doi.org/10.1158/1078-0432.30710179","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30710179","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1-S6_from_Urinary_Tumor_DNA_MRD_Analysis_to_Identify_Responders_to_Neoadjuvant_Immunotherapy_in_Muscle-invasive_Bladder_Cancer/30710179/1/files/59835013.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30710179","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Figure_S1-S6_from_Urinary_Tumor_DNA_MRD_Analysis_to_Identify_Responders_to_Neoadjuvant_Immunotherapy_in_Muscle-invasive_Bladder_Cancer/30710179","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30710179","doi":"https://doi.org/10.1158/1078-0432.30710179","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30710179","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S1-S6_from_Urinary_Tumor_DNA_MRD_Analysis_to_Identify_Responders_to_Neoadjuvant_Immunotherapy_in_Muscle-invasive_Bladder_Cancer/30710179/1/files/59835013.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416630105.pdf","grobid_xml":"https://content.openalex.org/works/W4416630105.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416629325","https://openalex.org/W4213201401","https://openalex.org/W4385514441","https://openalex.org/W4387602114","https://openalex.org/W3182417193","https://openalex.org/W3173023590","https://openalex.org/W4320484973","https://openalex.org/W4281760704","https://openalex.org/W4365509959","https://openalex.org/W7204465706"],"abstract_inverted_index":{"Figure":[0,49,157,231,319,493],"S1.":[1],"(A)":[2,51,159,233,321,495],"Representative":[3,13],"MRI":[4,118,152,366,395,460,505,583],"images":[5],"for":[6,18,77,162,410,507],"radiographic":[7],"evaluation":[8,20],"of":[9,21,58,81,100,166,181,252,283,356,385,414,425,439,501,554],"neoadjuvant":[10,22,123,332,347,440,511],"toripalimab.":[11,23,124,333,348,441,512],"(B)":[12,74,189,246,334,513],"hematoxylin":[14],"and":[15,69,96,121,168,177,194,212,254,260,280,285,345,365,394,504],"eosin":[16],"staining":[17],"histopathological":[19],"CR":[24],"=":[25,29,33,37,126,132,137,142,147,150,153,218,222,227,292,301,306,311,443,452,461,466,471,478,483,486,489,566,575,584,589,593,597,601,605,609,614,619,624,628,633,637,641,647,652],"complete":[26,144,480,611],"response;":[27,31,145,481,612],"PR":[28],"partial":[30],"SD":[32],"stable":[34],"disease;":[35,617],"PD":[36,651],"progressive":[38,563,653],"disease.":[39,492,564,654],"A":[40],"modifier":[41],"\u201cp\u201d":[42],"refers":[43],"to":[44,369,398],"pathologic":[45,437],"staging":[46],"after":[47,122,346],"cystectomy.":[48],"S2.":[50],"Stacked":[52,350,379],"bar":[53,351,380],"plot":[54,111,235,265,324,337,352,381,409,497,515,533],"shows":[55],"the":[56,78,97,106,163,178,187,250,354,370,383,399,411,431,436,535,555],"percentage":[57,355,384],"patients":[59,84,357,386],"with":[60,85,358,387,562],"negative":[61,70],"or":[62,66,71,87,360,389,547],"positive":[63,72],"PD-L1,":[64],"low":[65,359,388],"high":[67,361,390],"TMB,":[68],"TLS.":[73],"Oncoprint":[75,160],"chart":[76,161],"mutational":[79,164],"landscape":[80,165],"tDNA":[82,167,193,217,623],"in":[83,238,257,268,328,341,417,526,539,559],"ypCR":[86,141,477,608],"non-ypCR.":[88],"Samples":[89,170],"were":[90,171],"analyzed":[91,172],"by":[92,117,173,198,289,375,404,520,543],"whole":[93,174,199,548,620],"exome":[94,175,200,549,621],"sequencing,":[95,176],"mutation":[98,134,179,229,538,558],"frequencies":[99,180],"each":[101,182,426,508],"gene":[102,183],"are":[103,184,215,428],"shown":[104,185],"on":[105,186,297,316,448,457,571,580],"right.":[107,188],"(C)":[108,263,349,531],"The":[109,322,335,420],"line":[110,323,336],"illustrates":[112,325,338,516],"tumor":[113,133,219,224,228,293,303,308,312,444,453,468,567,576,625,630],"size":[114],"changes":[115,327,340,500,553],"measured":[116],"imaging":[119],"before":[120,344],"PD-L1":[125],"programmed":[127],"death":[128],"ligand":[129],"1;":[130,591,645],"TMB":[131,190,226],"burden;":[135],"TLS":[136],"tertiary":[138],"lymphoid":[139],"structure;":[140],"pathological":[143,479,610],"pre-tx":[146,482],"pre-treatment;":[148,484],"post-tx":[149,485],"post-treatment;":[151,487],"magnetic":[154,462,585],"resonance":[155,463,586],"imaging.":[156],"S3.":[158],"utDNA.":[169],"correlation":[191,209],"between":[192],"utDNA":[195,221,239,259,269,284,300,329,342,465,517,627],"as":[196,287],"assessed":[197],"sequencing.":[201,550],"Red":[202],"shading":[203],"indicates":[204,435],"95%":[205],"confidence":[206],"interval.":[207],"Spearman":[208],"coefficient":[210],"(r)":[211],"P":[213],"value":[214],"shown.":[216],"DNA;":[220,225,304,309,469,626,631],"urinary":[223,302,422,467,629],"burden.":[230],"S4.":[232],"Box":[234,264,514],"compares":[236,266],"TFsm":[237,291,326,442,521,565],"versus":[240,270,528],"ctDNA":[241,261,271,305],"samples":[242,272,330,343],"collected":[243],"at":[244,273],"baseline.":[245,274],"Venn":[247],"plots":[248],"show":[249],"number":[251,277],"shared":[253],"unique":[255],"variants":[256],"matched":[258],"samples.":[262,530],"TFcn":[267,310,339,451,523,574],"(D)":[275,378,551],"Copy":[276],"gain":[278],"(red)":[279],"loss":[281],"(blue)":[282],"ctDNA,":[286],"identified":[288],"GISTIC2.0.":[290],"fraction":[294,313,445,454,568,577],"estimate":[295,314,446,455,569,578],"based":[296,315,447,456,570,579],"somatic":[298,449,572],"mutations;":[299,450,573],"circulating":[307],"copy":[317,458,581],"numbers.":[318],"S5.":[320],"upon":[331],"showed":[353,382],"pre-treatment":[362,472],"TFsm,":[363,392,502],"TFcn,":[364,393,503],"measurements":[367,396,506],"according":[368,397],"optimal":[371,400],"cutoff":[372,401],"points":[373,402],"defined":[374,403],"ROC":[376,405],"analysis.":[377,406],"post-treatment":[391,421,638],"(E)":[407],"Waterfall":[408],"best":[412],"change":[413],"target":[415],"lesions":[416],"20":[418],"patients.":[419],"MRD":[423,488,544,613],"status":[424],"patient":[427,509,540,560],"arranged":[429],"along":[430],"x-axis.":[432],"Bar":[433],"color":[434],"outcome":[438],"numbers;":[459,582],"imaging;":[464,587],"utDNA-pre":[470,527,632],"utDNA;":[473,476,635,639],"utDNA-post":[474,529,636],"=post-treatment":[475],"minimal":[490,615],"residual":[491,616],"S6.":[494],"Spider":[496],"indicating":[498],"dynamic":[499],"during":[510],"reduction":[518],"(defined":[519],"+":[522],"<":[524],"10%)":[525],"IGV":[532],"showing":[534],"FGFR3":[536,556],"S249C":[537,557],"RZ12":[541,561],"detected":[542],"panel":[545],"sequencing":[546],"VAF":[552,646],"C1":[588],"cycle":[590,594,598,602,642],"C2":[592],"2;":[595],"C3":[596],"3;":[599],"C4":[600],"4;":[603],"RC":[604],"radical":[606],"cystectomy;":[607],"WES":[618],"sequencing;":[622],"pretreatment":[634],"C2D1":[640],"2":[643],"day":[644],"variant":[648],"allele":[649],"frequency;":[650]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4416630105","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2025-11-25T00:00:00"}
